Amber Therapeutics is a University of Oxford spinout developing next-generation, intelligent bioelectrical therapies to transform clinical outcomes in patients with functional disorders of the peripheral nervous system. Amber’s approach leverages closed-loop intelligence to create ‘synthetic reflex arcs’ that can sense, interpret, adapt and respond to a patient’s individual signals thereby restoring normal physiological function.

Amber Therapeutics was founded by a multidisciplinary team of clinicians, translational neuroengineers, medtech industry professionals and experienced entrepreneurs focused on developing transformational therapy innovation for major unmet medical conditions. The Company is backed by Oxford Science Enterprises and 8VC.

Health Care

Life Sciences

Therapeutics

Amber Therapeutics

Amber Therapeutics' headquarters in London, United Kingdom

Description

People (3)

Aidan Crawley

Tim Denison

Jacob Kerr

Jobs